Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials.
about
A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.Antidepressant treatment history as a predictor of response to scopolamine: clinical implications.The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome.Psychometric evaluation of the Snaith-Hamilton pleasure scale in adult outpatients with major depressive disorder.A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.Scopolamine produces larger antidepressant and antianxiety effects in women than in men.Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trialReplication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trialMaking clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRSPretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to ScopolamineThe Montgomery Asberg and the Hamilton ratings of depression: a comparison of measuresBaseline mood-state measures as predictors of antidepressant response to scopolamine.The effectiveness of antidepressant monotherapy in a naturalistic outpatient setting.The assessment of poststroke depression.Development of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder.Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.Measurement-based Treatment of Residual Symptoms Using Clinically Useful Depression Outcome Scale: Korean Validation Study.Tablet-based screening of depressive symptoms in quito, ecuador: efficiency in primary careThyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder.Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study.Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials.Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorderA proposed model for economic evaluations of major depressive disorder.Pilot Testing Behavior Therapy for Chronic Tic Disorders in Neurology and Developmental Pediatrics Clinics.A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.Cognitive behavioral therapy for body image and self-care (CBT-BISC) in sexual minority men living with HIV: A randomized controlled trial.Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy.The structure of the Montgomery-Åsberg depression rating scale over the course of treatment for depression.How to measure monetary losses in gambling disorder? An evidence-based refinement.
P2860
Q30955590-11172B54-DDEF-4F67-A6A5-72F522F19B27Q33647744-1499D6DB-9F2A-42E5-BD99-A29C35477479Q33899224-F4DEB5F6-CD76-4563-9750-460E426B699FQ34211262-6104B528-1C85-44AD-B0FD-47DC0314F7CCQ34590910-8A6EA46F-48E9-485A-B2D8-696203A82657Q34660507-0492747A-C407-4B15-8253-7E88F0174D04Q34743145-68BA2F5D-35C0-477A-AF51-0174DC53A2A9Q35648180-87F4CD82-B228-44E8-976B-9759B1C2A7E1Q35689739-1098F1F3-9C40-4A59-AA0B-A8E6EC38AA52Q36062843-896CC2A4-16C9-48E2-B092-DA4F16297874Q36064491-25B292AD-1110-44D3-8959-23C457C405B7Q36296747-773D3A23-3DA8-4C33-814C-A1DA5A6DC527Q36296905-3D4BE50A-72BE-426C-B969-006F6CD5B177Q36643293-BF867F20-452E-4499-8766-BA593925B37FQ36850989-38816E71-D3B2-41F8-B975-06A9E7E8BED3Q36860514-307B6F76-26E3-4377-985D-99E060DFEA06Q37029596-8AFD77EA-9909-49CF-BF99-C4134847D787Q37623117-92CEC9AF-6259-4B72-810C-3AE193DBD208Q37627298-F431CD2A-B469-410D-B974-F5FC0BC01497Q37670185-A2E71266-2770-42BE-91A9-BB76D53F6105Q39345467-2D28CA1E-51A6-451C-95B6-4819C4BBAC32Q40062026-DDC7AAA6-A2F6-45D3-9F93-F4B80C75AC76Q42061953-5A53B49C-C4FA-4857-BFB8-4FE93317FEC7Q42644229-D5DAA8CC-1B9E-460E-A1E8-8A0DA969FE2BQ42698655-A222576E-B4C0-4099-AE74-74A9A2FDD260Q44649934-7FE76F5F-9AEF-4431-BA1F-C2FEFBEB6DECQ45950732-724B2F09-D4E6-4828-8395-6B274B511E08Q46726992-8FD09C71-7121-409B-8F1A-DD2580ACCFA4Q47856745-9983BFED-F26D-4BAE-B20B-C7179475ABF3Q48031940-283D62BB-0533-4072-8E14-EE619A5888EAQ48425690-CA3755AD-523B-4B5E-9F6F-CECEABCFF6CDQ49588964-8AA90D8E-DA90-4C0D-BC26-97483E27F2DF
P2860
Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@ast
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@en
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@nl
type
label
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@ast
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@en
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@nl
prefLabel
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@ast
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@en
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@nl
P2093
P1476
Relative sensitivity of the Mo ...... ntidepressant clinical trials.
@en
P2093
P304
P356
10.1097/00004850-200211000-00003
P577
2002-11-01T00:00:00Z